biocon

Biocon Biologics Hulio launch, Hulio biosimilar Humira US, Biocon Biologics pricing strategy, Hulio patient-friendly device, Hulio market share US, Biocon Biologics Viatris acquisition, Hulio biosimilar approval FDA,

Biocon Biologicsā€™ CEO reveals pricing strategy and device design for Hulio, its Humira biosimilar, in the US market

Anika Sharma

The competition in the biosimilar arena targeting AbbVie’s blockbuster drug Humira, also known as adalimumab, is heating up. However, for ...

biocon, peter bains, group ceo, biopharmaceutical, sosei group, biocon expansion, biocon news

Biocon appoints Peter Bains as group CEO to lead its global expansion

Anika Sharma

Biocon has appointed Peter Bains as its new CEO as the company seeks to expand its presence in North America ...